Josh Enomoto

Josh Enomoto

InvestorPlace Contributor

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

For Beyond Meat Stock, the Devil Is in the Details

By Josh Enomoto, InvestorPlace Contributor

We all want to have our cake and eat it too, and Beyond Meat presumably offers that, thereby lifting the case for BYND stock. However, as you drill into the details, the picture doesn’t appear so bright and shiny.

7 Beverage Stocks to Stock Up On

By Josh Enomoto, InvestorPlace Contributor

Thanks to a diverse consumer base with various needs, these top beverage stocks should be able to outperform the broader markets in the coming years.

The Comfort Zone Is Holding Rite Aid Stock Back

By Josh Enomoto, InvestorPlace Contributor

Believe it or not, Rite Aid has the opportunity to maximize its revenue profile. But getting there is a herculean task, leaving Rite Aid stock an avenue best left for speculators.

7 Stocks to Sell Before They Roll Over

By Josh Enomoto, InvestorPlace Contributor

With the markets at all-time highs, no one is thinking about stocks to sell. And that’s one of the reasons why you should think exactly that.

IBM Stock Investors Overthink Q3 Miss, Ignoring Big Blue’s Resilience

By Josh Enomoto, InvestorPlace Contributor

After a very positive start to the year, IBM stock has largely moved sideways. Yet the markets’ lack of appreciation for International Business Machines' comprehensive cloud initiatives may be a hidden opportunity.

It’s All About the Weed for Aphria Stock

By Josh Enomoto, InvestorPlace Contributor

While Aphria’s growth capacity expansion is big news, a more critical catalyst for Aphria stock could be its medicinal marijuana brand.

Education Can Go a Long Way for Aurora Cannabis Stock

By Josh Enomoto, InvestorPlace Contributor

Wall Street has penalized Aurora Cannabis stock for the underlying company’s aggressive expansionary strategy. However, that expansion may have been necessary to bring to volume ACB’s premium-quality medicinal cannabis products.

3 Key Issues Advanced Micro Devices Stock Faces

By Josh Enomoto, InvestorPlace Contributor

Although AMD stock has been a top performer over the past few years, the longer-term case is starting to look dull for several different reasons. Here's what Advanced Micro investors should know.

Sentiment and a Reinvigorated Sector Make ATVI Stock a Smart Buy

By Josh Enomoto, InvestorPlace Contributor

Due to the resounding, record-breaking debut of Activision Blizzard’s Modern Warfare, it appears that gamers once again desire gritty realism in their shooter games. If so, that’s wonderful news for ATVI stock over the long haul.

The Good, Bad, and Ugly for Biogen Stock

By Josh Enomoto, InvestorPlace Contributor

With news that Biogen’s Alzheimer’s drug was allowed to reapply for possible FDA approval, Biogen stock skyrocketed. However, investors will want to carefully consider all angles before jumping onboard.

Load More